Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Comparison on bioactivities and characteristics of polysaccharides from four varieties of gastrodia elata blume
Presented for research literature review only Di Stefano G et al
Roches manufacturing and investment initiatives have been expansive, with the company having pledged up to $50 billion in US investments over five years for new R&D and production facilities, including a new $700 million drug plant in North Carolina and a $550 million diagnostics manufacturing expansion in Indianapolis for continuous glucose monitoring technology
From a sourcing standpoint, complex generics matter because they attract fewer ANDA filers than simple small molecules, produce shallower price erosion at LOE, and often require specialized manufacturing equipment that limits the supplier pool
US$ 24.40
US$ 27.28
US$ 23.70
US$ 23.18
US$ 22.98
